Extract Hematologic and globin synthesis $tudie$ were performed i n a hlack American family in which the genes for x-thalassemia and hemoglobins t H b ) S and C' were segregating. 'l'he following distribution o f these abnormalities was found: father. sickle cell trait + n-thalassemia; mother, H b C trait + a-thalaswmia, propositus, H b S C + a-thalassemia; older sibling, n-thalasscmia trait; and younger sibling, hemoglobin H disease. ' The child with HbSC'-e-thalasremia demonstrated more serere anemia and a more hemolytic picture than is typical of H h S < ' disease. H e r erythrocytes exhibited decreased osmotic fragility i n comparison with HbSC' er! throcytes, but had an indistinguishable oxygen equilibrium curre and 2.3-diphosphoglycerate (2,3-I)P(;) letel. Erythrocyte sickling in the patient, honeter, was significantly reduced, with less than 3 5 % sickle forms observed at nearly complete oxygen desaturation.
The sibling with hemoglobin H disease exhibited 26'2 Bart's ( y , ) hemoglobin at birth, a level comparable with that seen in infants with H b H disease in Far Eastern populations. A t age 5 months typical findings of mild hemoglobin H disease appeared.
with H b H making up 6.5% o f the total hemoglobin. Speculation I he prewnce o f tu-thalassemia in the proband o f thi\ rtudy appeared to modif, her HbSC direare r o as to reduce it$ clinical seterit!, ar n e l l ar its pathologic potential. The amelioratite effect o f tu-thalarremia would appear to he related to a reduction i n the intracellular hemoglobin concentration i n the patient'$ erythrocvter. hut other factors may alro be responriblc for there change$. Further study o f genetically modified sickle hemoglobinopathy ryndromer may ultimatcl! aid i n the detelopment o f effectite mcanr for the treatment o f there di$orderr. and clinical expression of the sickle hemoglobinopathies. In a number of atypical sickling disorders specific modifying factors have been identified that seem to alter the ability of the er) throcyte t o undergo sickle transformation. Other genetic traits appear t o modify the clinical expression of sickling disorders by different. but thus far unidentified mechanisms.
Abnormalities that have a genetic basis and are known t o modify sickle cell diseases inciude: associated hemoglobin (?-chain (19, 40) and P-chain (4. 23. 24) structural abnormalities, thalassemias and thalassemia-like disorders (1, 28. 35. 46) : variability in the production of fetal hemoglobin (2. 17) : and the presence of other associated hematologic disorders (22, 38) .
In this report we describe the clinical and hematologic findings of a child having an apparently modified form of hemoglobin SC disease related to the association of tr-thalassemia.
METHODS

HEMATOL.OGIC A N D Ht.MOGLOBIN STUDlhS
Hematologic measurements were made with a Coulter model S electronic cell counter which was standardized daily using a commercial standard. Other determinations were performed by standard methods (5). Osmotic fragility tests were carried out with fresh samples of defibrinated blood as described bk Dncie (8) .
Blood samples for hemoglobin analysis were collected in E D T A . T h e erythrocytes were isolatetl by centrifugation. washed three times in isotonic saline, and lysed with 2-3 volumes of water without the addition of an organic solvent. Stroma-free lysates were prepared and subjected to electrophoresis on cellulose-acetate strips in Tris-EDTA-borate buffer at pH 8.6 . For quantitative estimation of individual hemoglobins. the bands were excised after electrophoresis and the hemoglobins eluted and m e~~s u r e d as previously described (15) . Each indicated value represents the mean of determinations done at least in triplicate. Alk:~li-resistant hemoglobin was estimated according to the procedure of Betke rr al. (3) . DEAE-Sephadex column chromatography of carbon monoxide-saturated hemoglohins was performed as described by Dozy and coworkers (9).
Blood samples obtained for the globin synthesis determinations were collected in h e p a r~n and kept at ice tcmpcrature before the incubations. Washed cells. 1.0-ml packed cell volume. were incubated for 2 4 hr in niediuni containing 10 clC'i of L-['"]leucine (specific activit! 250 mCi/mmol). Thc incuhat~on procedure was as previously described (16) . Globin chromatography on carboxymethyl cellulose columns was performed b) thc method of Clegg and coworkers (7) . Equal itliquots of the chromaiugral)h~c effluent fractions were taken l i~r determinations of incorporated radioactivit) (16) : tu/O + 7 radioactivity ratios were calculated using the total incorporated radioactivlt! recovered from the chromatographic fractions corresponding to each of the glohin chains.
O X Y G t N A F t I N I I Y A N D SICKLlN(; S1lll)ltS Oxygen equilibrium curves were determined with a model 217 blood gas analyzer from Instrumentation Laboratories Inc., Lexington, Mass. Blood samples were equilibrated in the tonometer with varying mixtures of 5.60% C O , in air and 5.60'; C O , In nitrogen. After equilibration with each gas mixture. aliquots of the blood were withdrawn for measurement of the PO,, p H , and percentage of oxygen saturation. A normal alkaline Bohr factor was applied whenever neces5ary fbr correction of pO, values t o correspond t o pH 7. 40 .
Determinations of 2,3-DPG were performed using protcin-free trichloroacetic acid filtrates prepared from whole blood samples. A spectrophoiometric assay procedure was employed as described by Keitt (18) .
For enumeration of the percentages of sickled erythrocytes in relation t o oxygen saturation, aliquots of equilibrated blood samples also were drawn into syringes containing 5% formalin and 0.01 M N a , H P O , in isotonic saline. T h e formalin-fixed erythrocytes were examined in a hemocytometer counting chamber and classified according t o the criteria of Rampling and Sirs ( 3 1 ) . For each sample. 1,000 cells were counted.
All clinical studies were carried out with informed consent according to the provisions of the Declaration of Helsinki.
R ESU L.TS
CASE REPORTS
The patient, RC', a 7-year-old girl, was referred for hematologic evaluation in preparation for an adenoidectomy. She had had multiple episodes of otitis media. and had developed severe nasopharyngeal obstruction with persistant mouth-breathing. S h e was noted t o he anemic. and was found from a hemoglobin electrophoresis stud! to have hemoglohins S and C. Apart from the problems attributable to her tonsillar hypertrophy, the child had generallj, been health!.. S h e hird never been noted to have jaundice, fatigue, pain crisis, o r other clinical manifestation of sickle cell disease. She appeared somewhat pale and her spleen was enlarged extending 2 cm below the costal margin.
After completion of the hematologic evaluation the child was given a transfusion of packed red cells sufficient to increase her blood hemoglobin concentration t o I I .O g/dl. An adenoidectomy under general aneqthesia was performed without con~plication. and her recovery and subsequent course were uneventful.
The parents of the child and her 9-year-old sister had been in good health, and had not been known to have anemit1 o r other hematologic a b n o r n i a l~t~. During the time that the evaluation of the patient mas in progress. her mother gave birth to a I'ull term infant after an uneventful pregnancy. The infant did well during the neonatal period and showed no evidence of anemia orjaundice. Her subsequent course was without apparent complication. Hematologic studies of the infant were performed at birth and subsequently at the age of 5 months.
A faniil) pedigree. indicating the diagnosis ultirnatel) established for each of the f:~mily memberh. is shown in Figure I The results of hematologic studies of the patient and her family are presented In Tahle 1 . The patient (11-2) was moderi~tcly anemic with a persistently elevated reticulocyte count. H e r mean corpuscular volume ( M C V ) and hemoglobin ( M C H ) indice> were markedly reduced in splte of a normill serum iron level and total iron-binding capacity. Her blood sme:tr ( Fig. 2C') demon5trated many of the features typical of hen~oglobin S C disease erythrocytes, including the presence of target cells and "safety-pin" forms. T h e cclls appeared more flattened, however, and thin. symmetrical-appe~~ring target f;)rnia made up a majority of the erythrocytes seen in stained smears of her blood. Contracted. densely staining cells that resembled spherocytes were also regularly seen, but sickle forms were never observed. Hemoglobin electrophoresis of stroma-free hernol!sates from the patient demonstrated approximatelg equal quantities of hemoglobins S and C (Table 2 ). There n a s no significant elevation o f t h e level of her alkali-resistant hemoglobin.
Both parents of the patlent and her older sister (11-1) also \+ere mild11 anemic with niicrocytic erythroclte indices in the absence of demonstrable iron deficiency. Blood smear5 from the fcrthcr ( Fig.  2 A ) and the sister (11-1) demonstrated microcytosis but generally unremarkable erythrocyte rnorpholopy otherwise. The hlood srnear of the mother shoned an~soc!tosis. poikilocytosis. target and "pencil" form\, and "safet~-pin" cells ( Fig. 1 B ) .
Electrophoresis of hemoglobin I'rom the firther demonstrated :in A S 1~1 t t c r n a i t h H b S representing 2 6 . 0 5 of the total. Hls Hh.?\ and alkali-rwistant hemoglobin fractions were norrnal ( Table 1 ) . T h e rnother's hernoglobin electrophoresis stud! denionstratcd hemoglobins :I and C . Hemoglobins I\, + C made up 24'; of her total h e m o g l o h~n : her alkali-re.;istant fraction was also uithin the normal ranee. T h c older sister's hcnioglobin clectrophores~s pattern was normal, a s were the levels of H b A , and alkali-resistant hemoglobin.
Frejhl! draibn hlood samples I'rom the patient, her parents. and her older sister were incubated uith brilliant cresbl blue, and :i careful search n a s made for er~throc!tc inclu\ion bodies. but none were idcntificd.
The p:~tienr's o l l n 2 e r \rster (11-3). who u a 5 horn d u r~n g the course of the familk btudq. was not anemic at birth (Table I ) : [eiiiopliihin jtii.iis of the i n f . . r + ..
were rcpeated at aye 5 months, according to the methods dcscribcd above. In addition. \troma-free hemol!sates n e r e prepared froni her washed erythrocytes and the hemoglobin u a \ subjected t o D E A E -S e p h~i d e x column chromatograph>. T h e chrornatogr:~phic analysis at birth ( F I~. 3 ) demonstrated peal\\ of I l h A and Hbl' which accounted for 23.0'; and 50.6";. respectivel!. of the total hemoglobin. These peaks \\ere follo\\.ed hg a late-eluting peak that contained 26. 3 T o obtain ;i quantitatiix assessment of the balance bet~been the synthesi\ of n and non-a-globin proterns. globin synthesis studies were performed with peripher~ll hlood red cells from each of the famil! members.
Cilobin synthesis by blood reticulocytes from the mother (I-.?) u a s signlficantlq deficient in fi chain s)nthesis a s compared u i t h the synthesis of 8 chains (Fig. 4 ) . 'Phe glohin syntliesis studq performed wrth blood from the patient (11-2) (Fig. 5 ) also demonstrated a relative deficiency of L-['4C]leucine incorporation into the ru-globin fraction a s cornpared with the incorporation into @' t $". T h e glohin synthesis stud! of the infant (11-3) denionstrated : I reduced s y n t h c s i~ of (! chains a s compared with that of the @.I + y chains. both when she was studied at birth and at 5 months ol age.
The ( I / @ r -, synthesis ratios froni each of the famil) members a r c shown in Tahle 1. In every casc the ratio \+as s~gnil'icantl! less than those of nonthalc15srrnic control subjects ( I .O4 -. Osmotic frilgilitj n a s deterrnined with freshl? prepared er!throc j t e s from the patlent, and compared u~t h similarl) prep~ired sample5 from normal subjects and from patients with H b S C disease ( F i g . 6 ) . The patient's cells exhibited decreased osmotic fragility as compared to that of the H b S C erjthrocytes, which in turn showed decreased osmotic fragility relative to the norrnal control subjects.
The oxygen eyuilibr~um curve of fresh whole blood from the patient (Fig. 7 ) u n s shifted to the right ol'the normal curve. u i t h the pO, at 505? oxygen saturation being approximately 6 m m H g higher than that of the normal. Her blood oxygen equilibrium curve did not differ significantly, houever. from those obtained in clmol/g Hb.
In an effort to evaluate the sickling ability of the patient's erythrocytes, samples of her blood were equilibrated with gas mixtures of varying oxygen content to achieve a range of oxygen saturation values. and at each ~o i n t the number of sickled cells present was determined. The results of this study are shown in Figure 8 together with those obtained with blood samples from five patients with HbSC disease. At oxygen saturation levels of greater than 50% both the patient and the control subjects exhibited less than 20% of sickle cell forms. At saturation levels of less than 5 0 3 , the HbSC blood samples showed a nearly linear increase in the percentage of sickle cells as the oxygen saturation decreased, and reached more than 90% as total desaturation was approached. At oxygen saturation levels below 30%, the percentages of sickle cells in the HbSC-a thalassemia patient's blood were significantly less than those at corresponding oxygen saturation levels in the control subjects. Moreover, at the lowest oxygen saturation level achieved (about 4%) the patient's blood contained less than 35% sickle cell forms.
@-chain substitutions. These have included hemoglobins S (39,46), C (36), E (43), and J (41). T o our knowledge the patient described in this report represents the first known example of cu-thalassemia occurring in combination with hemoglobins S and C.
The asymptomatic clinical course of this patient may have been related to an ameliorative effect of the cu-thalassemia on her hemoglobinopathy: however, it has not been uncommon in our own experience for children with HbSC disease to be free of any symptom attrihutahle to sickle cell disease over a period of many years of observation. On the other hand, this patient demonstrated a more severe degree of anemia than we have usually encountered in children with HbSC disease, and her persistently elevated reticulocyte counts suggest a more hemolytic process than is typical of hemoglobin S C disease.
The oxygen equilibrium curve of the patient's blood was indistinguishable from that seen in HbSC disease, indicating a comparable degree of hemoglobin oxygen saturation in the two conditions at the same partial pressure of oxygen. However a direct enumeration of the numbers of sickled cells at varying oxygen tensions demonstrated a significantly reduced ability of the patient's erythrocytes to undergo sickle transformation. The apparent beneficial effect of the a-thalassemia in this patient is consistent with previous observations ( 39. 46 ) that cu-thalassemia reduced the severity of the clinical course of patients with sickle cell anemia. The reduced ability of the child's erythrocytes to sickle may be related to the diminished concentration of hemoglobin in her cells, in accordance with the observation of Seakins et a/. (33) that sickling is strongly influenced by the intracellular concentration of sickle hemoglobin. It is difficult to provide an explanation for the apparently more severe hemolytic process in this child in the presence of diminished erythrocyte sickling. Conceivably, the increased hemolysis is primarily related to some DISCUSSION Several examples have previously been described of cu-thalassemia occurring in combination with abnormal hemoglobins with other cause.
From available evidence, a-thalassemia appears to occur with high frequency in American blacks. Cord blood electrophoresis studies of black infants have suggested an incidence of a-thalassemia trait of between 2 and 7% (12. 25. 44). These studies all were FRACTION NO.
Fig. 3 . DEAE-Sephadex chromatography of hemoglobin prepared from cord blood erythrocytes of 11-3 (hemoglobin H disease).
based on the association between a-thalassemia and the presence of elevated levels (greater than 2%,) of Bart's (y,) hemoglobin detected at or near the time of birth. Although an increased level of Bart's hemoglobin in the neonatal period has been shown to correlate well with the presence of a-thalassemia, both by hematologic and globin biosynthesis criteria (12) . recent studies by Esan (10, 1 1 ) did not support an association of this kind in black infants in Nigeria. Most importantly, the author observed several pairs of monozygotic twins in which only one twin had an elevated level of Bart's hemoglobin. A similar example of hemoglobin Bart's disparity in identical twins was described by Pembrey and coworkers (30) from a study of a Saudi Arabian population. These observations suggest that at least in some cases elevated levels of Bart's hemoglobin at birth may be related to other, nongenetic factors. 6 . Osmotic frag~lity of fresh blood samples from normal controls, subjects with hemoglobin SC disease, and the patient with hernoglob~n SC-n-thalassemia. Thc rcsults shown from the patlent represent separate determinations performed several ueeks apart.
Beyond the neonatal period heterozygous forms of cu-thalassernia a r e particularly difficult to identify, and consequently few attempts have been made to determine the frequency of this disorder in older children and adults. Whereas elevated levels of hemoglobin A, and F serr,e to identif!: most heterorygous Sorms of @-thalassemia, these hemoglobins are characteristicallq present in normal a m o u n t s in a-thalassernia heterozygotes. t v e n microcqtosis, a feature shared by most forms of thalassemia, seems not to he reliable criterion for the identification of cu-thalassemiir trait. In a Greek population indiv~duals with hematologic and genetic I'eatures of n-thalassemia consistently had reduced M C V values (29), but studies of black infants (IZ), children (6) . and adults (37) with n-thalassemia showed that the iviCV indices may obcrial~ cur~siilcr-ably with the range of normal values.
When cu-thalassemia occurs in combination with sickle cell trait or H b C trait, however, the percentage of H b S o r H b C becomes significantly reduced in comparison with the usual amounts (35-45%) seen in h e t e r o~y g o u s individuals (6. 37). In the absence of iron deficiency ( 2 1 ) o r megaloblastic disease (13), t h~s finding provides a reliable means for establishing a diagnosis of n-thalassemia in adult life. T h e lower than usual percentages of hemoglobins S and C found in the parents of the proband in this study provide further confirmation o f t h i s relationship, and together with the globin synthesis determinations established in both of them the presence of cu-thalassemia.
T h e proband, with HbSC-cu thalassemia, apparently inherited the gene for hemoglobin S from her father, henioglob~n C from her mother, and cu-thalassemia from one of her parents. T h e older sister (11-1) derived a normal P-chain gene from her mother as well as from her father, and cu-thalassemia from one parent. T h e hematologic findings of the proband, the older sister, and both of her parents a r e characteristic of cu-thalassemia trait, although certain differences are apparent that can be related to the association with the different hemoglobin @-chain abnormalities present in each of them. T h e hematologic findings of the infant (It-.?) , particularly from the study performed when she was 5 months of age, are diagnostic of hemoglobin H disease, a more severe form of cu-thalassemia. c h a r a c t e r i~e d b) anemia, rnicrocytosis. a n d erythrocyte inclusions. and represents an tu-thalassemia ahnormality in which the tu-chain biosynthetic defect is of sufficient magnitude to produce a gross imbalance between n-chain and @-chain synthesis. with the formation of n~e a s u r a b l e quantities of @-chain tetramer molecules (hemoglobin H ) and intracellular precipitates composed of @-chain protein. This form of cu-thalassemia has been identified in many parts of the world with the highest frequencies reported in Mediterranean, Middle Eastern, and S o u t h East Asian populations (45) : it appears to occur quite uncommonly in black populations in Africa and in the United States. Hemoglobin H disease in American blacks has been studied in detail by Schwartr and Atwater (32) . who found that although the disorder shared most o f t h e features ofhemoglobin H FIF. 7 . Oxygeri equ~libriunl culve of I'rcsh whole blood from the SC-n-thalns\emia patlent. The deter~ii~n:~t~ons were performed at 37". ptl 7. 4 . The solid 11ne (--) rcprescnt\ the \\hole I,luod curve of nnrni;ll henloglohin A subjects.
Hemoglobin H disease is
% 0, SATURATION Fig. 8 . Sickling of the SC-n-thalassemia patient's erythrocytes in relation to oxygen saturation of the blood. 0-0: results ohta~nrd with blood from the patlcnt. The slzadrd circa indicates the mean and standard deviation of the curves obtained from five sub~ects h~t h hernogloh~n SC disease.
disease as it occurs in other populations, it is a significantly milder condition, both clinically and in terms of the a-chain biosynthetic defect, as determined by globin synthesis studies in vitro.
In Far Eastern populations in which cu-thalassemia occurs with high frequency, four hematologically distinct forms of a-thalassemia have been identified. These include a "silent-carrier" state, characterized by mild microcytosis but otherwise normal findings; cu-thalassemia trait, a condition characterized by abnormal erythrocyte morphology and hematologic features of mild thalassemia; hemoglobin H disease: and cu-thalassemia hydrops fetalis, a disorder that has been uniformly fatal in the newborn period and is accompanied by severe anemia and a total absence of hemoglobins A and F, with Bart's hemoglobin and HbH making up all of the hemoglobin present in the blood (45) . Family studies of individuals with hemoglobin H disease in these populations (42) have shown that in most instances one parent has tu-thalassemia trait and the other the n-thalassemia silent carrier state. On the other hand, the parents of infants with the hydrops fetalis form of cu-thalassemia both were shown to have the hematologic features of cu-thalasseniia trait (41).
These observations led to the conclusion (41) that two kinds of a-thalassemia genes exist in Far Eastern populations: a severe gene (cu-thal,) and one causing a lesser degree of impairment of cu-chain synthesis (tu-thal,). The hydrops fetalis syndrome was envisioned as representing the homozygous form of n-thal,. Inasmuch as infants having the hydrops fetalis form of n-thalassemia have been shown to be totally lacking the gene for hemoglobin cu-chains (27). it follows that the cu-thal, gene is an tun gene with no discernable gene product. The form of HbH disease seen in this population is accordingly thought to represent double heterozygosity for cu-thal, and cu-thal, (27), the latter being an t u + gene that produces only partial suppression of cu-chain synthesis.
The foregoing interpretation of genetic inforniation was based on a single-locus model which assumes the existence of single pair of n-chain genes. Recent evidence has been presented in support of the existence of two pairs of n-chain loci (14) , at least in some populations, and using a four gene model, Lehmann (20) suggested an alternative interpretation of the tu-thalassemia syndromes. His hypothesis assumed a single type of cu-thalassemia gene, which presumably caused complete suppression of a-chain synthesis. Using this model, the presence of I . 2, 3, or 4 cu-thalassemia genes corresponds, respectively, t o the silent carrier, cu-thalassemia trait, H b H disease, and the hydrops fetalis forms of the disease.
Either of the genetic models described appears adequate to account for the expression of tu-thalassemia as seen in Thai and other Far Eastern populations, but it has not been possible to account for the forms of tu-thalassemia that have been described in other population group<. In American blacks, Yemenite and Iraqui Jews (47)-and in Arabs in Saudi Arabia (30. 46) . the gene frequency of tu-thalassemia is substantial and HbH disease has been described: however, the hydrops fetalis a-thalassemia syndrome has never been identified.
In family studies of Yemenite and Iraqui .lewish families with HbH dlsease, ~nvolving determinations of both hemaroiogic i'eatures and globin synthesis (47) . an attempt was made to ident~fy mild and severe cu-thalassemia genes. The experimental findings did not, however, support the existence of more than a single type of cu-thalassemia gene and suggested that only two forms of a-thalassemia could be identified in this population, viz. a-thalassemia trait and HbH disease. It was proposed that these disorders could most readily be explained as representing, respectively, the heterozygous and homozygous expression of a single cu-thalassemia gene.
Pembrey and coworkers (30) , in their study of Arabs in Saudi Arabia, concluded that the findings in this population represented a form of cu-thalassemia that is expressed as a disorder of a severity intermediate between that of cu-thalassemia trait and HbH disease as they are known to occur in the Far East. As a possible explanation for these observations the authors postulated that six a-chain loci might be present in this population, allowing the expression of an intermediate fraction of the a-chain genes as Nthalassemia.
The genetics of cu-thalassemia in blacks remains unclear, but from available evidence seems to follow a pattern similar to that observed in the Yemenite and Iraqui Jews (47) . with cu-thalassemia trait and HbH disease apparently being the only clearly discernable forms of a-thalassemia in this population. The findings of a detailed study of black families with HbH disease, as reported by Schwartz and Atwater (32) , were consistent with this genetic pattern, but because of the mild degree of abnormality found in the globin synthesis studies of heterozygotes, rigorous proof of this hypothesis was lacking. An attempt has also been made to distinguish between mild and more severe forms of cu-thalassemia trait in blacks (34) , but a distinction of this kind remains unconvincing with the limited family studies that are available. The difficulty in identifying heterozygotes in adult life has been a major obstacle to the study of this condition and has caused a heavy reliance to be placed on the analysis of Bart's hemoglobin in the newborn period. The findings described by Esan (10, 1 I ) raise doubts about the total validity of this method as a means for the identification of cu-thalassemia in black populations and emphasize the need for confirming the diagnosis of n-thalassemia by other methods whenever possible.
Both of the parents of the infant with HbH disease described in this report appeared from the globin synthesis studies (Table 2) to have a form of cu-thalassemia of a similar degree of severity. This is consistent with each parent being heterozygous for a relative]) mild a-thalassemia gene (32) . although it is impossible from the evidence available to exclude a double dose of a still milder cu-thalassemia gene in either or both parents.
The limited genetic information now available about HbH disease in blacks, including the present case, seem clearly not to be explainable by the genetic mechanisms established in Far Eastern populations (41, 42). Two possible mechanisms that are consistent with the available genetic information are: ( I ) the presence of three or more n-chain loci in this population, with n-thalassemia genes of an n o type occupying an intermediate fraction of the total cu-loci in HbH individuals, to produce a thalassemic disorder less severe than that of HbH disease as seen in the Far East (30): or (2) the presence of a milder ( N -) type of n-thalassemia gene which does not produce complete suppression of cu-chain synthesis. The latter possibility does not necessarily exclude the existence of more than one type of cu-thalassemia gene (with respect to severity) in this population, and is compatible with either a 2-locus or 4-locus model. Inasmuch as P-thalassemia in blacks in the United States is mainly of the /3+ variety, cu-thalassem~;i may likewise cause incomplete suppression of cu-chain synthesis in this population.
In spite of the unquestionably milder expression of hemoglobin H disease in blacks as compared with other populations, it is of interest that the infant with HbH disease described in this report had a level of Bart's hemoglobin a t birth that was within the rangc of values seen in newborns with HbH disease in the Far East (36. 41). T o our knowledge this infant represents the only k n w n example oi' i~crriugioliin H disease in a blsck infan: ;;.hi: I, s l L I J .,-studied a t birth.
Hemoglobin H disease in American blacks was only first described in 1972 (32, 34) . The present case brings the total number of documented cases to nine. The apparent rarity of this condition seems surprising in view of evidence that the incidence o f cu-thalassemia among blacks is substantial, but several characteristics of the disorder as it occurs in the black population may serve to obscure its presence. Anemia is seldom severe in this form of H b H disease, and hemoglobin values may fall well within the range of normal values in affected individuals (32. 34) , allowing its presence to be overlooked. The now widespread application of hemoglobin electrophoresis testing for the detection of sickling disorders among blacks in the United States might also be expected to demonstrate the fast moving hemoglobin H fraction in otherwise asymptomatic and nonanemic individuals, but this finding is also likely to be missed; the preparation of hemolysates for electrophoresis testing in most hemoglobin screening laboratories includes the addition of toluene or chloroform t o aid in the removal of stromal material. but these chemicals have the unfortunate property of quantitatively precipitating hemoglobin H and thereby completely obscuring its presence in the electrophoretic analysis. Because of these and other diagnostic difficulties, a true assessment of the incidence of a-thalassemia and the various forms of its clinical expression in blacks will clearly require a prospective study employing multiple types of laboratory assessment and more definitive diagnostic criteria than heretofore have been employed.
S U M M A R Y
A 7-year-old black child with hemoglobin S C disease and microcytosis was found by hematologic and globin synthesis studies t o have concomitant a-thalassemia. 6 .5% of the total hemoglohin.
